Masako Seki

3.5k citations
40 papers · 2.7k indexed · h-index 20
Topics
Galectins and Cancer Biology (15 papers)Signaling Pathways in Disease (7 papers)Eosinophilic Esophagitis (4 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Masako Seki

38 papers receiving 2.6k citations

Peers

Masako Seki
Comparison fields: 5 of 119
  • Immunology 1.9k
  • Molecular Biology 1.2k
  • Oncology 423
  • Surgery 173
  • Organic Chemistry 135
Replace Wang He with:
Wang He China
Qixiang Shao China
Angela Gismondi Italy
Qiong Jiang China
Christian Termeer Germany
Liming Lu China
Matjaž Jeras Slovenia
Ramesh Bhonde India
Rieko Arakaki Japan
Masako Seki relative to Wang He China Wang He's profile →
Citations per field
00.5×6.8×
Wang He · 1×
Citations per year

Countries citing papers authored by Masako Seki

Since Specialization
Citations

This map shows the geographic impact of Masako Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Seki more than expected).

Fields of papers citing papers by Masako Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Seki. The network helps show where Masako Seki may publish in the future.

Co-authorship network of co-authors of Masako Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Seki. A scholar is included among the top collaborators of Masako Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Seki. Masako Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 51
2 19
3 395
4 95
5 40
6 20
7 3
8 257
9 140
10 166
11 126
12 103
13 81
14 128
15 6
16 258
17 3
18 2
19 2
20
FETAL ASCITES AND PORTAL DYSPLASIA OF THE LIVER (POLYCYSTIC DISEASE WITHOUT CYSTS) WITH PULMONARY ARTERIOVENOUS FISTULA AND CYSTIC LUNG.
12

About Masako Seki

Masako Seki is a scholar working on Immunology, Toxicology and Food Science, having authored 40 papers that have together received 2.7k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (15 papers), Signaling Pathways in Disease (7 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Immunology (1.9k citations), Molecular Biology (1.2k citations) and Oncology (423 citations). Masako Seki has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Mitsuomi Hirashima, Nozomu Nishi, Takanori Nakamura, Yumiko Kashio, Akira Yamauchi, Ryoji Matsumoto, Kazuhiro Nakamura, Naoki Saita, Naoko Yoshida and Aaron R. Rausen. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Applied and Environmental Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026